223 related articles for article (PubMed ID: 19710540)
1. Mechanistic study on growth suppression and apoptosis induction by targeting hepatoma-derived growth factor in human hepatocellular carcinoma HepG2 cells.
Tsang TY; Tang WY; Tsang WP; Co NN; Kong SK; Kwok TT
Cell Physiol Biochem; 2009; 24(3-4):253-62. PubMed ID: 19710540
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of hepatoma-derived growth factor activates the Bad-mediated apoptotic pathway in human cancer cells.
Tsang TY; Tang WY; Tsang WP; Co NN; Kong SK; Kwok TT
Apoptosis; 2008 Sep; 13(9):1135-47. PubMed ID: 18651222
[TBL] [Abstract][Full Text] [Related]
3. Fluoxetine Induces Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits ERK/NF-κB-Modulated Anti-Apoptotic and Invasive Potential in Hepatocellular Carcinoma Cells In Vitro.
Chen WT; Hsu FT; Liu YC; Chen CH; Hsu LC; Lin SS
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30754643
[TBL] [Abstract][Full Text] [Related]
4. Hepatoma-derived growth factor promotes growth and metastasis of hepatocellular carcinoma cells.
Yang GY; Zhang AQ; Wang J; Li CH; Wang XQ; Pan K; Zhou C; Dong JH
Cell Biochem Funct; 2016 Jun; 34(4):274-85. PubMed ID: 27273265
[TBL] [Abstract][Full Text] [Related]
5. Hepatoma-Derived Growth Factor: Its Possible Involvement in the Progression of Hepatocellular Carcinoma.
Enomoto H; Nakamura H; Liu W; Nishiguchi S
Int J Mol Sci; 2015 Jun; 16(6):14086-97. PubMed ID: 26101867
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma.
Shih TC; Tien YJ; Wen CJ; Yeh TS; Yu MC; Huang CH; Lee YS; Yen TC; Hsieh SY
J Hepatol; 2012 Sep; 57(3):584-91. PubMed ID: 22613005
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of HDGF Inhibits the Growth of Hepatocellular Carcinoma Cells In Vitro and In Vivo.
Enomoto H; Nakamura H; Liu W; Iwata Y; Nishikawa H; Takata R; Yoh K; Hasegawa K; Ishii A; Takashima T; Sakai Y; Aizawa N; Ikeda N; Iijima H; Nishiguchi S
Anticancer Res; 2015 Dec; 35(12):6475-9. PubMed ID: 26637859
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Bcl-2 protects human hepatoma cells from Fas-antibody-mediated apoptosis.
Takahashi M; Saito H; Okuyama T; Miyashita T; Kosuga M; Sumisa F; Yamada M; Ebinuma H; Ishii H
J Hepatol; 1999 Aug; 31(2):315-22. PubMed ID: 10453946
[TBL] [Abstract][Full Text] [Related]
9. Involvement of hepatoma-derived growth factor in the growth inhibition of hepatocellular carcinoma cells by vitamin K(2).
Yamamoto T; Nakamura H; Liu W; Cao K; Yoshikawa S; Enomoto H; Iwata Y; Koh N; Saito M; Imanishi H; Shimomura S; Iijima H; Hada T; Nishiguchi S
J Gastroenterol; 2009; 44(3):228-35. PubMed ID: 19214667
[TBL] [Abstract][Full Text] [Related]
10. IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas.
Tietze MK; Wuestefeld T; Paul Y; Zender L; Trautwein C; Manns MP; Kubicka S
Cancer Gene Ther; 2000 Oct; 7(10):1315-23. PubMed ID: 11059688
[TBL] [Abstract][Full Text] [Related]
11. Hepatoma-derived growth factor regulates the bad-mediated apoptotic pathway and induction of vascular endothelial growth factor in stomach cancer cells.
Lee KH; Choi EY; Kim MK; Lee SH; Jang BI; Kim TN; Kim SW; Kim SW; Song SK; Kim JR; Jung BC
Oncol Res; 2010; 19(2):67-76. PubMed ID: 21302807
[TBL] [Abstract][Full Text] [Related]
12. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
[TBL] [Abstract][Full Text] [Related]
13. Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis.
Chen SC; Hu TH; Huang CC; Kung ML; Chu TH; Yi LN; Huang ST; Chan HH; Chuang JH; Liu LF; Wu HC; Wu DC; Chang MC; Tai MH
Oncotarget; 2015 Jun; 6(18):16253-70. PubMed ID: 25938538
[TBL] [Abstract][Full Text] [Related]
14. Regulation of HSP27 on NF-kappaB pathway activation may be involved in metastatic hepatocellular carcinoma cells apoptosis.
Guo K; Kang NX; Li Y; Sun L; Gan L; Cui FJ; Gao MD; Liu KY
BMC Cancer; 2009 Mar; 9():100. PubMed ID: 19331697
[TBL] [Abstract][Full Text] [Related]
15. ShRNA-targeted COMMD7 suppresses hepatocellular carcinoma growth.
Zheng L; Liang P; Li J; Huang XB; Liu SC; Zhao HZ; Han KQ; Wang Z
PLoS One; 2012; 7(9):e45412. PubMed ID: 23049798
[TBL] [Abstract][Full Text] [Related]
16. NFATc1 is a tumor suppressor in hepatocellular carcinoma and induces tumor cell apoptosis by activating the FasL-mediated extrinsic signaling pathway.
Xu S; Shu P; Zou S; Shen X; Qu Y; Zhang Y; Sun K; Zhang J
Cancer Med; 2018 Sep; 7(9):4701-4717. PubMed ID: 30085405
[TBL] [Abstract][Full Text] [Related]
17. Wilms' tumor 1 gene modulates Fas-related death signals and anti-apoptotic functions in hepatocellular carcinoma.
Uesugi K; Hiasa Y; Tokumoto Y; Mashiba T; Koizumi Y; Hirooka M; Abe M; Matsuura B; Onji M
J Gastroenterol; 2013 Sep; 48(9):1069-80. PubMed ID: 23142971
[TBL] [Abstract][Full Text] [Related]
18. Hepatoma-derived growth factor: A survival-related protein in prostate oncogenesis and a potential target for vitamin K2.
Shetty A; Dasari S; Banerjee S; Gheewala T; Zheng G; Chen A; Kajdacsy-Balla A; Bosland MC; Munirathinam G
Urol Oncol; 2016 Nov; 34(11):483.e1-483.e8. PubMed ID: 27692835
[TBL] [Abstract][Full Text] [Related]
19. Role of hepatoma-derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma.
Min X; Wen J; Zhao L; Wang K; Li Q; Huang G; Liu J; Zhao X
Mol Oncol; 2018 Sep; 12(9):1480-1497. PubMed ID: 30004626
[TBL] [Abstract][Full Text] [Related]
20. Suppression of human hepatoma (HepG2) cell growth by nuclear factor-kappaB/p65 specific siRNA.
Wu W; Yao D; Wang Y; Qiu L; Sai W; Yang J; Yao N; Li S; Bian Y; Wang Z; Yao D
Tumour Biol; 2010 Dec; 31(6):605-11. PubMed ID: 20628843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
